Reshaping Nucleic Acids, Reversing Disease
Gene abnormalities often result in the manufacture of too little or too much protein, causing a myriad of life-threatening diseases, such as cancer.
Reglagene's medicines target the protein production problem at the source—the gene—and gets it back to functioning properly.
Reglagene develops Epigenetic Medicines that regulate cancer genes
Too often cancer survivors hear the life-shattering words, ‟Your cancer is back.” Cancer changes itself to nullify even the most effective treatments. Therapy resistance is the greatest challenge cancer patients face today. At Reglagene, we develop Epigenetic Medicines that attack the root causes of therapy resistance to keep cancer patients responsive to treatment.
When cancer is confronted with therapy, it responds with genetic modifications that alter its gene expression to become resistant. What patients need is a way to effectively reverse cancer's genetic changes that enable treatments to work better and longer. That's where Reglagene's Epigenetic Medicines become crucial in helping cancer patients overcome therapy resistance. Reglagene's Epigenetic Medicines target the gene itself and get it back to functioning properly.
Reglagene is on a mission to discover and develop low-cost and noninvasive therapeutic solutions that regain control of genes exploited by cancer. Our goal is to build medicines for a global market, not just for the wealthiest nations and individuals.
NEWS & UPDATES
1703 E Mabel St | Tucson, AZ 85721 | USA